Cardlytics (NASDAQ:CDLX) Price Target Cut to $3.00 by Analysts at Lake Street Capital

Cardlytics (NASDAQ:CDLX) had its target price reduced by stock analysts at Lake Street Capital from $5.00 to $3.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Lake Street Capital’s target price would indicate a potential upside of 21.46% from the stock’s previous close.

A number of other equities research analysts have also issued reports on CDLX. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research report on Thursday. Evercore ISI dropped their price target on Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $6.42.

Cardlytics Price Performance

CDLX stock opened at $2.47 on Thursday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The business has a 50 day simple moving average of $3.02 and a 200-day simple moving average of $3.50. The firm has a market capitalization of $125.53 million, a PE ratio of -0.40 and a beta of 1.62. Cardlytics has a 1 year low of $1.77 and a 1 year high of $20.52.

Insider Buying and Selling

In other Cardlytics news, CFO Alexis Desieno sold 24,778 shares of the company’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $84,245.20. Following the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Amit Gupta sold 15,160 shares of the company’s stock in a transaction on Friday, January 24th. The stock was sold at an average price of $3.92, for a total value of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares in the company, valued at $844,736.48. This trade represents a 6.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 111,454 shares of company stock worth $391,864. Company insiders own 4.40% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. GSA Capital Partners LLP lifted its stake in Cardlytics by 1,273.2% during the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock worth $1,223,000 after purchasing an additional 354,474 shares in the last quarter. RBF Capital LLC lifted its stake in Cardlytics by 311.9% during the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after purchasing an additional 369,620 shares in the last quarter. Geode Capital Management LLC lifted its stake in Cardlytics by 7.5% during the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after purchasing an additional 73,484 shares in the last quarter. Barclays PLC lifted its stake in Cardlytics by 223.9% during the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock worth $186,000 after purchasing an additional 40,112 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of Cardlytics by 38.2% in the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after acquiring an additional 5,392 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.